Chemical and Biological Therapeutic Approaches to Neurological Disorders III
The major neurological disorders; Alzheimer's disease, Parkinson's disease, epilepsy, cerebral vascular disease, including stroke, multiple sclerosis, brain trauma and migraine have a significant and increasing impact on the lives of millions of people and thus have emerged as a priority health problem worldwide. For many of these disorders treatment options are extremely limited owing to the fact that their pathogenesis is multifactorial and incompletely understood. The physical and mental toll on patients cannot be understated and the burden on their families and caregivers is enormous. There is also a tremendous economic burden on health providers and governments and this will increase as the expected global life span increases.
Neurological disorders together with mental health issues cost the UK, alone, ~112 billion (GBP), annually. Scientists have been striving to unravel the mechanisms of neurogenesis and to provide a medical pathway to the amelioration of the symptoms associated with these distressing disorders. Although many advances have been made in cell and gene therapy, molecular diagnostics, and imaging spectroscopy, there is still a long road ahead towards finding cures for neurological disorders. This symposium brings together some of the top influential researchers intent on solving the mechanisms involved that will move us ever closer to disease-modifying treatments, thus driving the field forward.
The RSC Biotechnology Group invites your attendance at this comprehensive meeting where the latest developments in this challenging area of neuroscience will be presented.